Avadel Pharmaceuticals PLC Strategic Asset Allocation Index
Avadel Pharmaceuticals PLC strategic asset allocation index. Avadel Pharmaceuticals PLC (AVDL) has a Strategic Asset Allocation Index of 8.4% as of June 2023. Strategic assets (PP&E of $12.05 Million plus long-term investments of $-) total $12.05 Million, measured against net assets of $143.19 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Avadel Pharmaceuticals PLC tangible equity quality to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Avadel Pharmaceuticals PLC (2000–2021)
Strategic asset allocation index of Avadel Pharmaceuticals PLC from 2000 to 2021. This chart shows how Avadel Pharmaceuticals PLC's Strategic Asset Allocation Index has evolved across 20 annual periods from 2000 to 2021. As of June 2023, the index stands at 8.4%, representing strategic assets of $12.05 Million against net assets of $143.19 Million USD.
Avadel Pharmaceuticals PLC Strategic Asset Allocation Index by Year (2000–2021)
Avadel Pharmaceuticals PLC strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Avadel Pharmaceuticals PLC from 2000 to 2021, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AVDL market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.4% | $285.00K | $285.00K | $- | $78.24 Million | ▲ +0.1 pp |
| 2020 | 0.2% | $359.00K | $359.00K | $- | $162.27 Million | ▼ -68.5 pp |
| 2018 | 68.7% | $1.91 Million | $1.91 Million | $- | $2.78 Million | ▲ +65.2 pp |
| 2017 | 3.5% | $3.00 Million | $3.00 Million | $- | $84.56 Million | ▼ -4.3 pp |
| 2016 | 7.9% | $3.32 Million | $3.32 Million | $- | $42.07 Million | ▲ +4.0 pp |
| 2015 | 3.9% | $2.62 Million | $2.62 Million | $- | $67.86 Million | ▼ -3.3 pp |
| 2014 | 7.1% | $1.78 Million | $1.78 Million | $- | $24.89 Million | ▼ -52.7 pp |
| 2012 | 59.8% | $18.24 Million | $18.24 Million | $- | $30.50 Million | ▼ -5.3 pp |
| 2011 | 65.1% | $19.38 Million | $19.38 Million | $- | $29.79 Million | ▲ +6.0 pp |
| 2010 | 59.0% | $21.43 Million | $21.43 Million | $- | $36.30 Million | ▲ +3.8 pp |
| 2009 | 55.2% | $24.76 Million | $24.76 Million | $- | $44.86 Million | ▼ -1.7 pp |
| 2008 | 56.9% | $27.60 Million | $27.60 Million | $- | $48.55 Million | ▼ -7.5 pp |
| 2007 | 64.3% | $35.14 Million | $35.14 Million | $- | $54.63 Million | ▲ +29.1 pp |
| 2006 | 35.2% | $25.70 Million | $25.70 Million | $- | $73.03 Million | ▲ +9.4 pp |
| 2005 | 25.8% | $22.32 Million | $22.32 Million | $- | $86.65 Million | ▲ +10.2 pp |
| 2004 | 15.6% | $18.16 Million | $18.16 Million | $- | $116.76 Million | ▲ +10.0 pp |
| 2003 | 5.5% | $5.08 Million | $5.08 Million | $- | $92.06 Million | ▼ -22.2 pp |
| 2002 | 27.7% | $3.40 Million | $3.40 Million | $- | $12.29 Million | ▼ -7.9 pp |
| 2001 | 35.6% | $2.67 Million | $2.67 Million | $- | $7.51 Million | ▲ +8.7 pp |
| 2000 | 26.9% | $2.92 Million | $2.92 Million | $- | $10.88 Million | — |